OpenAI Acquires Orchestra Bio to Build Drug-Development Agents
OpenAI is combining Orchestra Bio with Rosalind to automate the coordination layer of drug development, extending AI from discovery into execution.
It shows OpenAI moving beyond scientific assistance to control the operational layer that turns biological discoveries into drug programs.